Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recombinant Sheep Fibronectin Type-III Domain-Containing Protein (FNDC5)

Cat. No.AP9C718

Product TypeAnimal Proteins

Size

Product Overview

BioVenic's Recombinant Sheep Fibronectin Type-III Domain-Containing Protein (FNDC5) is a recombinant protein expressed from E.coli. Its predicted molecular weight is 22.8 kDa. The purity is>85% (SDS-PAGE).

Specifications

Type Recombinant Protein
Species Sheep
Expression System E.coli
Purity >85% (SDS-PAGE)
Predicted Molecular Weight 22.8 kDa
Physical State Lyophilized
Formulation The buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.

Target Information

Sheep fibronectin type III domain containing 5 (FNDC5), also known as irisin, is a protein involved in various physiological processes in sheep. FNDC5 is synthesized in muscle and upon proteolytic cleavage, it produces irisin, which is thought to play a role in the regulation of metabolism, particularly in the conversion of white adipose tissue to beige adipose tissue, enhancing energy expenditure and thermogenesis. This protein may also contribute to overall health and metabolic efficiency in sheep species.

Protein Sheep Fibronectin Type-III Domain-Containing Protein (FNDC5)
Gene ID 101104971
UniProt ID W5QI94

Shipping and Storage

This product is shipped with dry ice. It is recommended to aliquote as needed and store at -80°C upon receipt. Reconstituted protein solution can be stored at 4°C for 1 week, at < -80°C for 12 months. Avoid repeated freezing and thawing.

Documents

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

User Note

  1. Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Reconstitute in sterile distilled water to a concentration of 0.1-1.0 mg/mL.Aliquote the reconstituted solution to minimise freeze-thaw cycles.
Inquiry Basket